Bovine viral diarrhea

The World Market for Veterinary Diagnostics, 7th Edition - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 6, 2024

The "World Market for Veterinary Diagnostics, 7th Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "World Market for Veterinary Diagnostics, 7th Edition" report has been added to ResearchAndMarkets.com's offering.
  • Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory.
  • The World Market for Veterinary Diagnostics, 7th Edition meticulously examines the global veterinary diagnostics market, focusing on two key components: companion animal (pets) diagnostics and food animal diagnostics.
  • The report provides a comprehensive analysis of major veterinary disease markets, offering insights into overall market performance and development.

The World Market for Veterinary Diagnostics 2021-2026: Featuring Key Players IDEXX, Thermo Fisher Scientific, Heska Corporation and Zoetis - ResearchAndMarkets.com

Retrieved on: 
Monday, March 7, 2022

The "The World Market for Veterinary Diagnostics, 5th Edition " report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The World Market for Veterinary Diagnostics, 5th Edition " report has been added to ResearchAndMarkets.com's offering.
  • The World Market for Veterinary Diagnostics, 5th Edition examines the worldwide veterinary diagnostics market through the performance of its two component markets of companion animal and food animal diagnostics.
  • The report provides an analysis of major veterinary disease markets as well as overall market performance and development.
  • Total Global Animal Diagnostic Testing Market, 2021-2026 (in millions $ at manufacturer level)
    Global Veterinary Diagnostic Testing Market Share by Region (%) 2021 (US, Europe, Asia Pacific, RoW)
    Food Animal Diagnostics Market by Infectious Disease (Bovine Viral Diarrhea [BVD], Classical Swine Fever [CSF], Enzootic Bovine Leukosis [EBL], Infectious Bovine Tracheitis [IBR], Porcine Coronavirus Diseases [PEDv, PDCoV, TGE], Porcine Reproductive and Respiratory Syndrome [PRRS], Pseudorabies/Aujeszky's, Transmissible Spongiform Encephalopathies [TSEs], Other) (% and $ millions) 2021
    The World Market for Veterinary Diagnostics, 5th Edition contains the following market data points for both the food animal and companion animal segments:
    Global Animal Diagnostic Testing Market by Animal Segment, 2021-2026 (in millions $ at manufacturer level)
    Veterinary Companion Diagnostics Market Segmentation 2021 (Companion Animal: Clinical Chemistry, Infectious disease, Hematology, Other Analyzers, Non-infect Immunodiagnostics, Molecular, Other Testing, Total; Food Animal: Immunodiagnostic Test Kits, Molecular Diagnostics, Clinical Chemistry, Other Infectious Disease Test Reagents, Total) ($million; %)
    Market Size and Growth for United States Diagnostic Testing Market, 2021-2026 ($millions)
    Market Size and Growth for European Diagnostics Testing Market, 2021-2026 ($millions)
    Market Size and Growth for Asia Pacific Diagnostic Testing Market, 2021-2026 ($millions)
    Asia Pacific Diagnostic Testing by Country Percent 2018 (Japan, Philippines, China, India, Others)
    Market Size and Growth for Rest of World Diagnostic Testing Market, 2021-2026 ($millions)
    RoW Companion Animal Diagnostic Testing by Country Percent 2021 (Companion Animal: Canada, Australia, Brazil, Mexico, Others; Food Animal: Canada, Brazil, Mexico, Others)

xCures launches xACCESS - A new module in their AI-assisted clinical platform

Retrieved on: 
Tuesday, November 17, 2020

SAN FRANCISCO, Nov. 17, 2020 /PRNewswire/ -- Today, xCures Inc. is launching xACCESS - a new registration module for their AI-assisted clinical study platform.

Key Points: 
  • SAN FRANCISCO, Nov. 17, 2020 /PRNewswire/ -- Today, xCures Inc. is launching xACCESS - a new registration module for their AI-assisted clinical study platform.
  • The xCures platform uses a Master Observational Registry to efficiently run a wide variety of oncology studies and decentralized trials, prospectively generating real-world evidence.
  • "xACCESS is xCures' first patient-centric technology module, onboarding patients directly to our sponsored studies and partner programs," stated Mika Newton, xCures' CEO.
  • The xACCESS module will be used for all clinical studies and programs available on the xCures platform, including the recently announced Compassionate Use program for ulixertinib (BVD-523), currently enrolling patients with MAPK pathway aberrant cancer.